Biomolecules & Therapeutics

The Korean Society of Applied Pharmacology (한국응용약물학회)
권호 표지

Pharmacokinetic Study of Promethazine in Korean Healthy Subjects Using a Validated HPLC Method

  • Published : 2005.06.01
Download PDF
⟨ Previous Next ⟩

Abstract

The objective of the present investigation was to study pharmacokinetics of promethazine in Korean healthy subjects using a validated HPLC method. The HPLC analysis was performed on a Capcell Pak CN column with a mixture of acetonitrile-0.02M potassium dihydrogen phosphate (42:58, v/v, pH 6.0) and the analyte was quantified with UV detection at 251 nm. The calibration curve of the drug was linear over the range of 1-40ng/mL in human serum and the limit of quantification (LOQ) was 1 ng/mL. This analytical method was validated and shown to be specific, accurate, precise and reproducible. This method was applied to pharmacokinetic study of promethazine in Korean healthy volunteers following an oral administration of two 25 mg Himazin tablets (50 mg promethazine ${\cdot}$HCI) after overnight fasting. Serum samples were collected at given intervals over a 36-hour period (12 points) and pharmacokinetic parameters were determined from serum concentration-time profile using WinNonlin program. The estimated $AUC_{0__\infty}$, $AUC_{0_\infty}$, $C_{max}$, $T_{max}$ and $t_{1/2}$ of promethazine obtained from Korean healthy subjects were 103.84 ${\pm}$84.30 ng${\cdot}$hr/mL, 87.94${\pm}$81.02 ng${\cdot}$hr/mL, 13.43${\pm}$10.92 ng/mL, 2.00${\pm}$1.16 hr and 5.88${\pm}$3.47 hr, respectively.

Keywords

References

  1. Bagli, M., Rao, M. L., Hoflich, G. (1994) Quantification of chlorprothixene, levomepromazine and promethazine in human serum using high-performance liquid chromatography with coulometric electrochemical detection. J Chromatogr. B Biomed. Appl. 657, 141-148 https://doi.org/10.1016/0378-4347(94)80080-4
  2. DiGregorio G. J. and Ruch E. (1980) Human whole blood and parotid saliva concentrations of oral and intramuscular promethazine. J Pharm. Sci. 69, 1457-1459 https://doi.org/10.1002/jps.2600691234
  3. Fox, A.R. and McLoughlin D. A. (1993) Rapid, sensitive high-performance liquid chromatographic method for the quantification of promethazine in human serum with electrochemical detection. J Chromatogr. 631, 255-259 https://doi.org/10.1016/0021-9673(93)80530-L
  4. Lackner, J. R. and Graybiel, A. (1994). Use of promethazine to hasten adaptation to provocative motion. J Clin. Pharmacal. 34, 644-648 https://doi.org/10.1002/j.1552-4604.1994.tb02018.x
  5. Pistos, C. and Stewart, J. T. (2003). Direct injection HPLC method for the determination of selected phenothiazines in plasma using a Hisep column. Biomed. Chromatogr. 17, 465-470 https://doi.org/10.1002/bmc.275
  6. Quinn J. and Calvert R. (1976). The disposition of promethazine in man [proceedings]. J Pharm. Pharmacol. 28, suppl-59
  7. Schwinghammer, T. L., Juhl, R. P., Dittert, L. W., Melethil, S. K., Kroboth, F. J. and Chung, V.S. (1984). Comparison of the bioavailability of oral, rectal and intramuscular promethazine. Biopharm. Drug Dispos. 5, 185-194 https://doi.org/10.1002/bdd.2510050212
  8. Song, Q. and Putcha, L. (2001) Quantitation of promethazine and metabolites in urine samples using on-line solid-phase extraction and column-switching. J Chromatogr. B. 763, 920
  9. Stavchansky, S., Wallace, J. E., Geary, R., Hecht, G.., Robb, C. A. and Wu, P. (1987). Bioequivalence and phannacokinetic profile of promethazine hydrochloride suppositories in humans. J Pharm. Sci. 76, 441-445 https://doi.org/10.1002/jps.2600760606
  10. Strenkoski-Nix, L.C., Ermer, J., DeCleene, S., Cevallos, W. and Mayer, P.R. (2000). Pharmacokinetics of promethazine hydrochloride after administration of rectal suppositories and oral syrup to healthy subjects. Am. J Health-Syst. Pharm. 57, 1499-1505
  11. Tarkkila, P., Tom, K., Tuominen, M. and Lindgren, L. (1995). Premedication with promethazine and transdermal scopolamine reduces the incidence of nausea and vomiting after intrathecal morphine. Acta Anaesthesiol. Scand. 39, 983-986 https://doi.org/10.1111/j.1399-6576.1995.tb04210.x
  12. Taylor, G.., Houston, J. B., Shaffer J. and Mawer, G. (1983). Pharmacokinetics of promethazine and its sulphoxide metabolite after intravenous and oral administration to man. Br. J Clin. Pharmacol. 15, 287-293 https://doi.org/10.1111/j.1365-2125.1983.tb01501.x
  13. Temdrup, T. E., Dire, D. J., Madden. C. M., Davis, H., Cantor, R. M. and Gavula, D. P. (1991). A prospective analysis of intramuscular meperidine, promethazine, and chlorpromazine in pediatric emergency department patients. Ann. Emerg. Med. 20, 31-35 https://doi.org/10.1016/S0196-0644(05)81114-X
  14. Vanapalli, S. R., Kambhampati, S. P., Putcha, L. and Bourne, D. W. A. (2001). A liquid chromatographic method for the simultaneous determination of promethazine and three of its metabolites in plasma using electrochemical and UV detectors. J Chromatogr. Sci., 39, 70-72 https://doi.org/10.1093/chromsci/39.2.70
  15. Wallace, J. E., Shimek, E. Jr., Stavchansky, S. and Harris, S. C. (1981). Determination of promethazine and other phenothiazine compounds by liquid chromatography with electrochemical detection. Anal. Chem. 53, 960-962 https://doi.org/10.1021/ac00230a007
  16. Zaman, R., Honigberg, I. L., Francisco, G. E., Kotzan J. A., Stewart, J. T., Brown W. J., Shah. V. P. and Pelsor, F. R. (1986). Bioequivalency and dose proportionality of three tableted promethazine products. Biopharm. Drug Dispos. 7, 281-291 https://doi.org/10.1002/bdd.2510070309